Evaluation Of The Efficacy And Safety Of Probiotic Formulation With Zinc Enriched Yeast In Children With Acute Diarrhea

M. Maladkar, P. Moralwar, Praveen Mody, V. Yewale, Upendra Kinjawadekar, M. Mohite
{"title":"Evaluation Of The Efficacy And Safety Of Probiotic Formulation With Zinc Enriched Yeast In Children With Acute Diarrhea","authors":"M. Maladkar, P. Moralwar, Praveen Mody, V. Yewale, Upendra Kinjawadekar, M. Mohite","doi":"10.5580/16f4","DOIUrl":null,"url":null,"abstract":"Background: Diarrhea is a common and potentially serious illness in early childhood. A child suffers, on an average, 10 to 15 episodes of diarrhea in the first five years of life. Particularly in developing countries like India this problem is much more common and also severe due to poor hygiene and less accessible healthcare facilities compared to western world. Objective: The objective of the study was to evaluate the efficacy and safety of a probiotic formulation with Zinc enriched yeast in children with acute diarrhea. Materials and Methods: This was an open label, non-randomized clinical trial conducted on outpatient basis by the qualified investigators at five different centers. A total of 104 pediatric patients (6-60 months of age) with acute diarrhea of < 48 hrs duration were enrolled in the study. The enrollment of the patients was as per inclusion/exclusion criteria. After obtaining informed consent they were individually examined, investigated and treated as per study protocol. The treatment included daily one sachet of Lactobacillus rhamnosus Rosell-11 (1Billion cells), Saccharomyces boulardii (125mg) along with Zinc enriched yeast (equivalent to elemental Zinc 20mg) for 1014 days. Results: Within studied population, 60% patients with acute diarrhea showed complete recovery from their symptoms by day 3, 35% by day 5 and remaining 5% of patients by day 10. These patients showed symptomatic improvement in all studied parameters which included, both stool frequency and consistency, episodes of vomiting and urination frequency. It was observed that 95 % of patients resumed normal food intake & activities in 5 days. As per investigator’s assessment, the efficacy of the treatment with trial medication was good and very good in 89 patients and satisfactory in 11 patients. Among the 100 patients studied, 20 patients rated the therapy with the trial medication as very good, 69 patients as good and 11 patients as satisfactory. All the patients reported good tolerability of the formulation with no serious adverse events. Conclusion: The present study concludes that once a day administration of probiotic-zinc combination containing Lactobacillus rhamnosus Rosell-11, Saccharomyces boulardii and zinc enriched yeast is effective in the treatment of acute diarrhea and associated symptoms. Source of support: The study was sponsored by Aristo Pharmaceuticals Pvt. Ltd. Mumbai.","PeriodicalId":339404,"journal":{"name":"The Internet Journal of Nutrition and Wellness","volume":"123 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Nutrition and Wellness","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/16f4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Diarrhea is a common and potentially serious illness in early childhood. A child suffers, on an average, 10 to 15 episodes of diarrhea in the first five years of life. Particularly in developing countries like India this problem is much more common and also severe due to poor hygiene and less accessible healthcare facilities compared to western world. Objective: The objective of the study was to evaluate the efficacy and safety of a probiotic formulation with Zinc enriched yeast in children with acute diarrhea. Materials and Methods: This was an open label, non-randomized clinical trial conducted on outpatient basis by the qualified investigators at five different centers. A total of 104 pediatric patients (6-60 months of age) with acute diarrhea of < 48 hrs duration were enrolled in the study. The enrollment of the patients was as per inclusion/exclusion criteria. After obtaining informed consent they were individually examined, investigated and treated as per study protocol. The treatment included daily one sachet of Lactobacillus rhamnosus Rosell-11 (1Billion cells), Saccharomyces boulardii (125mg) along with Zinc enriched yeast (equivalent to elemental Zinc 20mg) for 1014 days. Results: Within studied population, 60% patients with acute diarrhea showed complete recovery from their symptoms by day 3, 35% by day 5 and remaining 5% of patients by day 10. These patients showed symptomatic improvement in all studied parameters which included, both stool frequency and consistency, episodes of vomiting and urination frequency. It was observed that 95 % of patients resumed normal food intake & activities in 5 days. As per investigator’s assessment, the efficacy of the treatment with trial medication was good and very good in 89 patients and satisfactory in 11 patients. Among the 100 patients studied, 20 patients rated the therapy with the trial medication as very good, 69 patients as good and 11 patients as satisfactory. All the patients reported good tolerability of the formulation with no serious adverse events. Conclusion: The present study concludes that once a day administration of probiotic-zinc combination containing Lactobacillus rhamnosus Rosell-11, Saccharomyces boulardii and zinc enriched yeast is effective in the treatment of acute diarrhea and associated symptoms. Source of support: The study was sponsored by Aristo Pharmaceuticals Pvt. Ltd. Mumbai.
富锌酵母益生菌制剂治疗儿童急性腹泻的疗效和安全性评价
背景:腹泻是儿童早期常见且潜在严重的疾病。一个孩子在5岁前平均会腹泻10到15次。特别是在像印度这样的发展中国家,由于卫生条件差和医疗设施不足,与西方国家相比,这个问题更为普遍,也更为严重。目的:本研究的目的是评价一种富含锌酵母的益生菌制剂对儿童急性腹泻的疗效和安全性。材料和方法:这是一项开放标签、非随机临床试验,在门诊基础上由五个不同中心的合格研究者进行。共有104名急性腹泻持续时间< 48小时的儿童患者(6-60个月)参加了这项研究。患者的入组按照纳入/排除标准进行。在获得知情同意后,按照研究方案对他们进行单独检查、调查和处理。处理包括每天一袋鼠李糖乳杆菌rosel -11(10亿个细胞),博拉迪酵母菌(125mg)以及富锌酵母(相当于元素锌20mg),持续1014天。结果:在研究人群中,60%的急性腹泻患者在第3天完全康复,35%的患者在第5天完全康复,其余5%的患者在第10天完全康复。这些患者在所有研究参数中均表现出症状改善,包括大便频率和稠度、呕吐次数和排尿次数。观察到95%的患者在5天内恢复正常的食物摄入和活动。经研究者评价,89例患者的临床疗效为好、极好,11例患者满意。在研究的100名患者中,20名患者认为试验药物治疗非常好,69名患者认为良好,11名患者认为满意。所有患者均报告该制剂耐受性良好,无严重不良事件。结论:含鼠李糖乳杆菌rosel -11、博拉氏酵母菌和富锌酵母的益生菌-锌联合治疗急性腹泻及相关症状,每日1次。支持来源:本研究由Aristo Pharmaceuticals Pvt. Ltd.赞助。孟买。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信